Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

Authors

Roberta Laureana (ORCID: https://orcid.org/0009-0008-5374-6056)

Publication Details

Journal: Mediterranean Journal of Hematology and Infectious Diseases
Published: 2026-10-31
DOI: https://doi.org/10.4084/mjhid.2026.090
Primary Topic: Chronic Lymphocytic Leukemia Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

Roberta Laureana

Oct 31, 2026

Mediterranean Journal of Hematology and Infectious Diseases

Chronic Lymphocytic Leukemia Research

article

Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

Roberta Laureana

October 31, 2026article en

Abstract

No abstract available for this paper.

Mediterranean Journal of Hematology and Infectious DiseasesVol. 18(1)

Openalex Percentile: Top 12%

Chronic Lymphocytic Leukemia Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon

Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience — Roberta Laureana · Mediterranean Journal of Hematology and Infectious Diseases (2026) | TGRS Research Map | TGRS